nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—SPDEF—ovarian cancer	0.0206	0.0599	CbGpPWpGaD
Clobetasol propionate—Tingling sensation—Melphalan—ovarian cancer	0.0164	0.0267	CcSEcCtD
Clobetasol propionate—Secondary infection—Epirubicin—ovarian cancer	0.015	0.0245	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—ovarian cancer	0.0139	0.0227	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Paclitaxel—ovarian cancer	0.013	0.0212	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptors—NR5A1—ovarian cancer	0.0124	0.0359	CbGpPWpGaD
Clobetasol propionate—Folliculitis—Paclitaxel—ovarian cancer	0.0123	0.02	CcSEcCtD
Clobetasol propionate—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.0122	0.0355	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—ovarian cancer	0.0114	0.033	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.0111	0.0323	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.0111	0.0323	CbGpPWpGaD
Clobetasol propionate—Skin hyperpigmentation—Docetaxel—ovarian cancer	0.011	0.0179	CcSEcCtD
Clobetasol propionate—Eruption—Docetaxel—ovarian cancer	0.0106	0.0173	CcSEcCtD
Clobetasol propionate—Infection—Carboplatin—ovarian cancer	0.0104	0.0169	CcSEcCtD
Clobetasol propionate—Leukoderma—Epirubicin—ovarian cancer	0.0104	0.0169	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00976	0.0283	CbGpPWpGaD
Clobetasol propionate—Leukoderma—Doxorubicin—ovarian cancer	0.00961	0.0157	CcSEcCtD
Clobetasol propionate—Tingling sensation—Paclitaxel—ovarian cancer	0.00961	0.0157	CcSEcCtD
Clobetasol propionate—Eye irritation—Paclitaxel—ovarian cancer	0.00905	0.0147	CcSEcCtD
Clobetasol propionate—Pain—Carboplatin—ovarian cancer	0.00895	0.0146	CcSEcCtD
Clobetasol propionate—Tenderness—Paclitaxel—ovarian cancer	0.00885	0.0144	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.0083	0.0241	CbGpPWpGaD
Clobetasol propionate—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—ovarian cancer	0.00796	0.0231	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.0078	0.0227	CbGpPWpGaD
Clobetasol propionate—Fluticasone Propionate—PGR—ovarian cancer	0.00775	0.185	CrCbGaD
Clobetasol propionate—Eye irritation—Docetaxel—ovarian cancer	0.00767	0.0125	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Epirubicin—ovarian cancer	0.00743	0.0121	CcSEcCtD
Clobetasol propionate—Eruption—Epirubicin—ovarian cancer	0.00718	0.0117	CcSEcCtD
Clobetasol propionate—Betamethasone—PGR—ovarian cancer	0.00711	0.17	CrCbGaD
Clobetasol propionate—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.0071	0.0206	CbGpPWpGaD
Clobetasol propionate—Psoriasis—Epirubicin—ovarian cancer	0.00703	0.0115	CcSEcCtD
Clobetasol propionate—Folliculitis—Epirubicin—ovarian cancer	0.00703	0.0115	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—ovarian cancer	0.00687	0.0112	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Topotecan—ovarian cancer	0.00671	0.0109	CcSEcCtD
Clobetasol propionate—Alopecia—Chlorambucil—ovarian cancer	0.00669	0.0109	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—ovarian cancer	0.00664	0.0108	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—ovarian cancer	0.0065	0.0106	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—ovarian cancer	0.0065	0.0106	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Melphalan—ovarian cancer	0.00649	0.0106	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen metabolism—CYP1B1—ovarian cancer	0.0064	0.0186	CbGpPWpGaD
Clobetasol propionate—NR3C1—Nuclear Receptors—PGR—ovarian cancer	0.00615	0.0179	CbGpPWpGaD
Clobetasol propionate—Alopecia—Topotecan—ovarian cancer	0.00596	0.00971	CcSEcCtD
Clobetasol propionate—Alopecia—Melphalan—ovarian cancer	0.00583	0.00951	CcSEcCtD
Clobetasol propionate—Fluoxymesterone—ESR1—ovarian cancer	0.00576	0.137	CrCbGaD
Clobetasol propionate—Hypoaesthesia—Vinorelbine—ovarian cancer	0.00574	0.00935	CcSEcCtD
Clobetasol propionate—NR3C1—Endoderm Differentiation—HNF1B—ovarian cancer	0.00572	0.0166	CbGpPWpGaD
Clobetasol propionate—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00567	0.00924	CcSEcCtD
Clobetasol propionate—CYP1A1—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00566	0.0164	CbGpPWpGaD
Clobetasol propionate—Pain in extremity—Paclitaxel—ovarian cancer	0.00561	0.00914	CcSEcCtD
Clobetasol propionate—Rash pustular—Epirubicin—ovarian cancer	0.00554	0.00903	CcSEcCtD
Clobetasol propionate—Stinging—Epirubicin—ovarian cancer	0.00545	0.00888	CcSEcCtD
Clobetasol propionate—Glycosuria—Epirubicin—ovarian cancer	0.00545	0.00888	CcSEcCtD
Clobetasol propionate—Infection—Chlorambucil—ovarian cancer	0.00535	0.00871	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.00529	0.0154	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.00521	0.0151	CbGpPWpGaD
Clobetasol propionate—Dry skin—Paclitaxel—ovarian cancer	0.00514	0.00838	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—ovarian cancer	0.00512	0.00835	CcSEcCtD
Clobetasol propionate—Alopecia—Vinorelbine—ovarian cancer	0.0051	0.00831	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—ovarian cancer	0.00504	0.00822	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—ovarian cancer	0.00504	0.00822	CcSEcCtD
Clobetasol propionate—Erythema—Vinorelbine—ovarian cancer	0.00502	0.00818	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00496	0.00809	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00486	0.0141	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00486	0.00792	CcSEcCtD
Clobetasol propionate—Infection—Topotecan—ovarian cancer	0.00476	0.00776	CcSEcCtD
Clobetasol propionate—Pain in extremity—Docetaxel—ovarian cancer	0.00475	0.00775	CcSEcCtD
Clobetasol propionate—Infection—Melphalan—ovarian cancer	0.00466	0.00759	CcSEcCtD
Clobetasol propionate—Skin disorder—Topotecan—ovarian cancer	0.00465	0.00758	CcSEcCtD
Clobetasol propionate—Pain—Chlorambucil—ovarian cancer	0.0046	0.0075	CcSEcCtD
Clobetasol propionate—Skin disorder—Melphalan—ovarian cancer	0.00456	0.00742	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—ATF3—ovarian cancer	0.00438	0.0127	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00437	0.00713	CcSEcCtD
Clobetasol propionate—CYP1A1—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.00437	0.0127	CbGpPWpGaD
Clobetasol propionate—Dermatitis contact—Epirubicin—ovarian cancer	0.00436	0.00711	CcSEcCtD
Clobetasol propionate—Dry skin—Docetaxel—ovarian cancer	0.00436	0.0071	CcSEcCtD
Clobetasol propionate—Paraesthesia—Topotecan—ovarian cancer	0.0043	0.00701	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00425	0.00692	CcSEcCtD
Clobetasol propionate—Paraesthesia—Melphalan—ovarian cancer	0.00421	0.00686	CcSEcCtD
Clobetasol propionate—Dexamethasone—PGR—ovarian cancer	0.00413	0.0986	CrCbGaD
Clobetasol propionate—Pain—Topotecan—ovarian cancer	0.0041	0.00668	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.00408	0.0118	CbGpPWpGaD
Clobetasol propionate—Infection—Vinorelbine—ovarian cancer	0.00407	0.00663	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—ovarian cancer	0.00404	0.00658	CcSEcCtD
Clobetasol propionate—Pain—Melphalan—ovarian cancer	0.00401	0.00654	CcSEcCtD
Clobetasol propionate—Skin disorder—Vinorelbine—ovarian cancer	0.00398	0.00649	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00396	0.00646	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.0039	0.0113	CbGpPWpGaD
Clobetasol propionate—Dexamethasone—CYP1B1—ovarian cancer	0.00386	0.0922	CrCbGaD
Clobetasol propionate—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00386	0.00629	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Paclitaxel—ovarian cancer	0.00382	0.00623	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00381	0.00621	CcSEcCtD
Clobetasol propionate—Pruritus—Chlorambucil—ovarian cancer	0.00381	0.0062	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidative Stress—SOD1—ovarian cancer	0.00379	0.011	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Vinorelbine—ovarian cancer	0.00368	0.006	CcSEcCtD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—ovarian cancer	0.00364	0.0106	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00361	0.0105	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—RBL2—ovarian cancer	0.00361	0.0105	CbGpPWpGaD
Clobetasol propionate—Vascular purpura—Epirubicin—ovarian cancer	0.00358	0.00584	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Topotecan—ovarian cancer	0.00353	0.00575	CcSEcCtD
Clobetasol propionate—Pain—Vinorelbine—ovarian cancer	0.0035	0.00571	CcSEcCtD
Clobetasol propionate—Fluticasone furoate—ABCB1—ovarian cancer	0.00346	0.0826	CrCbGaD
Clobetasol propionate—Hypersensitivity—Melphalan—ovarian cancer	0.00346	0.00563	CcSEcCtD
Clobetasol propionate—Alopecia—Paclitaxel—ovarian cancer	0.00343	0.00559	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidative Stress—SOD2—ovarian cancer	0.00341	0.0099	CbGpPWpGaD
Clobetasol propionate—Pruritus—Topotecan—ovarian cancer	0.00339	0.00552	CcSEcCtD
Clobetasol propionate—Erythema—Paclitaxel—ovarian cancer	0.00338	0.0055	CcSEcCtD
Clobetasol propionate—Purpura—Epirubicin—ovarian cancer	0.00333	0.00542	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.00332	0.00965	CbGpPWpGaD
Clobetasol propionate—Pruritus—Melphalan—ovarian cancer	0.00332	0.00541	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—ovarian cancer	0.00332	0.0054	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptors—ESR1—ovarian cancer	0.00329	0.00954	CbGpPWpGaD
Clobetasol propionate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—ovarian cancer	0.00329	0.00954	CbGpPWpGaD
Clobetasol propionate—Hypoaesthesia—Docetaxel—ovarian cancer	0.00327	0.00533	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Docetaxel—ovarian cancer	0.00324	0.00528	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Docetaxel—ovarian cancer	0.00323	0.00527	CcSEcCtD
Clobetasol propionate—Pain in extremity—Epirubicin—ovarian cancer	0.00321	0.00523	CcSEcCtD
Clobetasol propionate—Purpura—Doxorubicin—ovarian cancer	0.00308	0.00502	CcSEcCtD
Clobetasol propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—ovarian cancer	0.00306	0.00888	CbGpPWpGaD
Clobetasol propionate—Rash—Topotecan—ovarian cancer	0.00302	0.00492	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.00302	0.00877	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00302	0.00877	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.00302	0.00877	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00302	0.00492	CcSEcCtD
Clobetasol propionate—Dermatitis—Topotecan—ovarian cancer	0.00302	0.00492	CcSEcCtD
Clobetasol propionate—Headache—Topotecan—ovarian cancer	0.003	0.00489	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—ovarian cancer	0.00297	0.00483	CcSEcCtD
Clobetasol propionate—Rash—Melphalan—ovarian cancer	0.00296	0.00482	CcSEcCtD
Clobetasol propionate—Dermatitis—Melphalan—ovarian cancer	0.00295	0.00482	CcSEcCtD
Clobetasol propionate—Dry skin—Epirubicin—ovarian cancer	0.00294	0.00479	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.00292	0.00847	CbGpPWpGaD
Clobetasol propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—ovarian cancer	0.00291	0.00845	CbGpPWpGaD
Clobetasol propionate—Alopecia—Docetaxel—ovarian cancer	0.00291	0.00474	CcSEcCtD
Clobetasol propionate—Pruritus—Vinorelbine—ovarian cancer	0.0029	0.00472	CcSEcCtD
Clobetasol propionate—Erythema—Docetaxel—ovarian cancer	0.00286	0.00467	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00286	0.00465	CcSEcCtD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.00283	0.0082	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.00279	0.00809	CbGpPWpGaD
Clobetasol propionate—Methylprednisolone—ABCB1—ovarian cancer	0.00276	0.0658	CrCbGaD
Clobetasol propionate—Infection—Paclitaxel—ovarian cancer	0.00274	0.00446	CcSEcCtD
Clobetasol propionate—Dry skin—Doxorubicin—ovarian cancer	0.00272	0.00443	CcSEcCtD
Clobetasol propionate—Skin disorder—Paclitaxel—ovarian cancer	0.00268	0.00436	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.0026	0.00754	CbGpPWpGaD
Clobetasol propionate—Rash—Vinorelbine—ovarian cancer	0.00258	0.00421	CcSEcCtD
Clobetasol propionate—Dermatitis—Vinorelbine—ovarian cancer	0.00258	0.00421	CcSEcCtD
Clobetasol propionate—Headache—Vinorelbine—ovarian cancer	0.00257	0.00418	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Epirubicin—ovarian cancer	0.0025	0.00407	CcSEcCtD
Clobetasol propionate—Paraesthesia—Paclitaxel—ovarian cancer	0.00247	0.00403	CcSEcCtD
Clobetasol propionate—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00244	0.00709	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00242	0.00394	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00241	0.007	CbGpPWpGaD
Clobetasol propionate—Pain—Paclitaxel—ovarian cancer	0.00236	0.00384	CcSEcCtD
Clobetasol propionate—Infection—Docetaxel—ovarian cancer	0.00232	0.00378	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00231	0.00377	CcSEcCtD
Clobetasol propionate—Skin disorder—Docetaxel—ovarian cancer	0.00227	0.0037	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Epirubicin—ovarian cancer	0.00221	0.0036	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Epirubicin—ovarian cancer	0.00218	0.00356	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Epirubicin—ovarian cancer	0.00218	0.00355	CcSEcCtD
Clobetasol propionate—NR3C1—Adipogenesis—GADD45A—ovarian cancer	0.00215	0.00623	CbGpPWpGaD
Clobetasol propionate—Prednisone—ABCB1—ovarian cancer	0.00211	0.0504	CrCbGaD
Clobetasol propionate—Paraesthesia—Docetaxel—ovarian cancer	0.0021	0.00342	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00204	0.00333	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00203	0.00331	CcSEcCtD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—YAP1—ovarian cancer	0.00203	0.00588	CbGpPWpGaD
Clobetasol propionate—Oedema peripheral—Doxorubicin—ovarian cancer	0.00202	0.00329	CcSEcCtD
Clobetasol propionate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00202	0.00586	CbGpPWpGaD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00202	0.00329	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—ESR1—ovarian cancer	0.00202	0.00585	CbGpPWpGaD
Clobetasol propionate—Pain—Docetaxel—ovarian cancer	0.002	0.00326	CcSEcCtD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—IL6—ovarian cancer	0.00199	0.00577	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—ovarian cancer	0.00198	0.00575	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00198	0.00575	CbGpPWpGaD
Clobetasol propionate—Alopecia—Epirubicin—ovarian cancer	0.00196	0.00319	CcSEcCtD
Clobetasol propionate—Pruritus—Paclitaxel—ovarian cancer	0.00195	0.00318	CcSEcCtD
Clobetasol propionate—NR3C1—Endoderm Differentiation—APC—ovarian cancer	0.00195	0.00566	CbGpPWpGaD
Clobetasol propionate—Prednisolone—ABCB1—ovarian cancer	0.00195	0.0464	CrCbGaD
Clobetasol propionate—Erythema—Epirubicin—ovarian cancer	0.00193	0.00315	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.00193	0.00559	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.00193	0.00559	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00193	0.00559	CbGpPWpGaD
Clobetasol propionate—Betamethasone—ABCB1—ovarian cancer	0.00191	0.0455	CrCbGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.0019	0.00551	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.00186	0.0054	CbGpPWpGaD
Clobetasol propionate—Alopecia—Doxorubicin—ovarian cancer	0.00181	0.00296	CcSEcCtD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.0018	0.00523	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.00179	0.00521	CbGpPWpGaD
Clobetasol propionate—Erythema—Doxorubicin—ovarian cancer	0.00179	0.00291	CcSEcCtD
Clobetasol propionate—Rash—Paclitaxel—ovarian cancer	0.00174	0.00283	CcSEcCtD
Clobetasol propionate—Dermatitis—Paclitaxel—ovarian cancer	0.00174	0.00283	CcSEcCtD
Clobetasol propionate—Headache—Paclitaxel—ovarian cancer	0.00173	0.00281	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Docetaxel—ovarian cancer	0.00172	0.00281	CcSEcCtD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—NR5A1—ovarian cancer	0.00169	0.0049	CbGpPWpGaD
Clobetasol propionate—Pruritus—Docetaxel—ovarian cancer	0.00165	0.00269	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00163	0.00266	CcSEcCtD
Clobetasol propionate—Infection—Epirubicin—ovarian cancer	0.00157	0.00255	CcSEcCtD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00156	0.00452	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00154	0.00446	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Epirubicin—ovarian cancer	0.00153	0.00249	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00151	0.00246	CcSEcCtD
Clobetasol propionate—Rash—Docetaxel—ovarian cancer	0.00147	0.0024	CcSEcCtD
Clobetasol propionate—Dermatitis—Docetaxel—ovarian cancer	0.00147	0.0024	CcSEcCtD
Clobetasol propionate—Headache—Docetaxel—ovarian cancer	0.00146	0.00239	CcSEcCtD
Clobetasol propionate—Infection—Doxorubicin—ovarian cancer	0.00145	0.00236	CcSEcCtD
Clobetasol propionate—Skin disorder—Doxorubicin—ovarian cancer	0.00142	0.00231	CcSEcCtD
Clobetasol propionate—Paraesthesia—Epirubicin—ovarian cancer	0.00141	0.00231	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CXCL8—ovarian cancer	0.0014	0.00407	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.00137	0.00398	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—ovarian cancer	0.00137	0.00396	CbGpPWpGaD
Clobetasol propionate—Pain—Epirubicin—ovarian cancer	0.00135	0.0022	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL2—ovarian cancer	0.00134	0.00389	CbGpPWpGaD
Clobetasol propionate—NR3C1—Endoderm Differentiation—CTNNB1—ovarian cancer	0.00132	0.00384	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Doxorubicin—ovarian cancer	0.00131	0.00213	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CCND1—ovarian cancer	0.00131	0.00379	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.00129	0.00376	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.00129	0.00374	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.00129	0.00374	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MMP9—ovarian cancer	0.00127	0.00368	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00126	0.00366	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.00126	0.00366	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—PTEN—ovarian cancer	0.00126	0.00366	CbGpPWpGaD
Clobetasol propionate—Pain—Doxorubicin—ovarian cancer	0.00125	0.00203	CcSEcCtD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—ovarian cancer	0.00124	0.00359	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.00121	0.00351	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—IL6ST—ovarian cancer	0.00121	0.00351	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL2—ovarian cancer	0.00118	0.00343	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Epirubicin—ovarian cancer	0.00116	0.00189	CcSEcCtD
Clobetasol propionate—NR3C1—Gene Expression—WDR77—ovarian cancer	0.00114	0.00331	CbGpPWpGaD
Clobetasol propionate—Pruritus—Epirubicin—ovarian cancer	0.00111	0.00182	CcSEcCtD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—ovarian cancer	0.00111	0.00323	CbGpPWpGaD
Clobetasol propionate—Dexamethasone—ABCB1—ovarian cancer	0.00111	0.0265	CrCbGaD
Clobetasol propionate—Hypersensitivity—Doxorubicin—ovarian cancer	0.00107	0.00175	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.00107	0.00311	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.00106	0.00307	CbGpPWpGaD
Clobetasol propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.00105	0.00306	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—CYP1B1—ovarian cancer	0.00105	0.00305	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MYC—ovarian cancer	0.00105	0.00304	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00104	0.00301	CbGpPWpGaD
Clobetasol propionate—Pruritus—Doxorubicin—ovarian cancer	0.00103	0.00168	CcSEcCtD
Clobetasol propionate—Rash—Epirubicin—ovarian cancer	0.000994	0.00162	CcSEcCtD
Clobetasol propionate—Dermatitis—Epirubicin—ovarian cancer	0.000993	0.00162	CcSEcCtD
Clobetasol propionate—Headache—Epirubicin—ovarian cancer	0.000987	0.00161	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000987	0.00286	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000965	0.0028	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000965	0.0028	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000965	0.0028	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—YAP1—ovarian cancer	0.000962	0.00279	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—ovarian cancer	0.00095	0.00276	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000933	0.00271	CbGpPWpGaD
Clobetasol propionate—Rash—Doxorubicin—ovarian cancer	0.000919	0.0015	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—ovarian cancer	0.000918	0.0015	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—ovarian cancer	0.000913	0.00149	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000912	0.00265	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—ovarian cancer	0.000904	0.00262	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—TTF1—ovarian cancer	0.000894	0.0026	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TP53—ovarian cancer	0.000861	0.0025	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—PGR—ovarian cancer	0.00084	0.00244	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000822	0.00239	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000822	0.00239	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—NR5A1—ovarian cancer	0.000812	0.00236	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000811	0.00235	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000804	0.00234	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—CTNNB1—ovarian cancer	0.000789	0.00229	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL6—ovarian cancer	0.000788	0.00229	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—PARP1—ovarian cancer	0.000781	0.00227	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000775	0.00225	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	0.000759	0.0022	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000739	0.00214	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000707	0.00205	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	0.000694	0.00202	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—STAT3—ovarian cancer	0.000688	0.002	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000684	0.00198	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000682	0.00198	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000675	0.00196	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.00067	0.00195	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000661	0.00192	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000647	0.00188	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NME2—ovarian cancer	0.000641	0.00186	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	0.000641	0.00186	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000629	0.00183	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000615	0.00179	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000615	0.00179	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000615	0.00179	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.0006	0.00174	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000581	0.00169	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000544	0.00158	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000517	0.0015	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000494	0.00143	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—IL6—ovarian cancer	0.00048	0.00139	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—YAP1—ovarian cancer	0.000463	0.00134	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	0.000448	0.0013	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000443	0.00129	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000415	0.0012	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYTB—ovarian cancer	0.000413	0.0012	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NME2—ovarian cancer	0.000409	0.00119	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PGR—ovarian cancer	0.000404	0.00117	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000404	0.00117	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PARP1—ovarian cancer	0.000376	0.00109	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PPP1CC—ovarian cancer	0.000361	0.00105	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—BRIP1—ovarian cancer	0.000361	0.00105	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000347	0.00101	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	0.000305	0.000885	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000283	0.000821	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYTB—ovarian cancer	0.000263	0.000765	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000263	0.000764	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000257	0.000747	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—YAP1—ovarian cancer	0.000242	0.000703	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.00024	0.000696	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	0.000233	0.000677	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PPP1CC—ovarian cancer	0.00023	0.000668	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—BRIP1—ovarian cancer	0.00023	0.000668	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—ESR1—ovarian cancer	0.000216	0.000627	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000211	0.000612	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—FASN—ovarian cancer	0.000197	0.000573	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SLC5A5—ovarian cancer	0.000194	0.000564	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SLC2A1—ovarian cancer	0.000188	0.000544	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000184	0.000533	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP1B1—ovarian cancer	0.00018	0.000522	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000168	0.000487	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	0.000159	0.000463	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000159	0.000461	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—YAP1—ovarian cancer	0.000154	0.000448	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000153	0.000444	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ABCB1—ovarian cancer	0.000148	0.00043	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—TYMS—ovarian cancer	0.000145	0.000422	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000134	0.00039	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—FASN—ovarian cancer	0.000126	0.000365	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SLC5A5—ovarian cancer	0.000124	0.000359	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SLC2A1—ovarian cancer	0.00012	0.000347	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CAV1—ovarian cancer	0.000117	0.00034	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000117	0.00034	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MAPK3—ovarian cancer	0.000115	0.000335	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP1B1—ovarian cancer	0.000115	0.000333	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MYC—ovarian cancer	0.000112	0.000326	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000112	0.000325	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CG—ovarian cancer	0.000107	0.00031	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	0.000102	0.000295	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000101	0.000294	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ABCB1—ovarian cancer	9.44e-05	0.000274	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CD—ovarian cancer	9.38e-05	0.000272	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—TYMS—ovarian cancer	9.27e-05	0.000269	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CB—ovarian cancer	8.18e-05	0.000237	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—AKT1—ovarian cancer	7.79e-05	0.000226	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CAV1—ovarian cancer	7.47e-05	0.000217	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.14e-05	0.000207	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTEN—ovarian cancer	7.07e-05	0.000205	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CG—ovarian cancer	6.81e-05	0.000198	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CD—ovarian cancer	5.98e-05	0.000174	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CB—ovarian cancer	5.22e-05	0.000151	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CA—ovarian cancer	4.99e-05	0.000145	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTEN—ovarian cancer	4.51e-05	0.000131	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKT1—ovarian cancer	4.07e-05	0.000118	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CA—ovarian cancer	3.18e-05	9.23e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKT1—ovarian cancer	2.6e-05	7.54e-05	CbGpPWpGaD
